Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-047132

MELINTA THERAPEUTICS, INC. /NEW/ · MLNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Prabhavathi Fernandes
Officer — President and CEO · Director
Period of report
May 22, 2015
Accepted (ET)
May 27, 2015 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 22, 2015M13,123$7.62A232,412D
Common StockMay 22, 2015M15,266$13.10A247,678D
Common StockMay 22, 2015M9,000$2.09A256,678D
Common StockF1May 22, 2015S9,000$35.721D247,678D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F5$2.09May 22, 2015M9,000A—Aug 9, 2019Common Stock82,19473,194D
Employee Stock Option (Right to Buy)F8$7.62May 22, 2015M13,123A—Mar 19, 2022Common Stock100,00086,877D
Employee Stock Option (Right to Buy)F12$13.10May 22, 2015M15,266A—Jan 7, 2024Common Stock125,000109,734D
Employee Stock Option (Right to Buy)F2$23.51holding————Dec 31, 2024Common Stock133,499133,499D
Employee Stock Option (Right to Buy)F3$1.43holding————Aug 7, 2016Common Stock12,1050D
Employee Stock Option (Right to Buy)F4$2.47holding————Jun 3, 2018Common Stock54,27354,273D
Employee Stock Option (Right to Buy)F6$2.09holding————Jul 28, 2020Common Stock34,13334,133D
Employee Stock Option (Right to Buy)F7$2.09holding————Dec 7, 2020Common Stock40,69840,698D
Employee Stock Option (Right to Buy)F9$6.63holding————Jan 17, 2023Common Stock150,000150,000D
Employee Stock Option (Right to Buy)F10$6.64holding————Mar 6, 2023Common Stock50,00050,000D
Employee Stock Option (Right to Buy)F11$13.10holding————Jan 7, 2024Common Stock50,00050,000D

Explanation of responses